← Back to Screener
Zimmer Biomet Holdings, Inc. (ZBH)
Price$94.78
Favorite Metrics
Price vs S&P 500 (26W)-8.22%
Price vs S&P 500 (4W)-0.07%
Market Capitalization$18.79B
P/E Ratio (Annual)26.65x
Indicated Dividend Yield (Annual)1.04%
All Metrics
P/CF (Annual)11.07x
Book Value / Share (Quarterly)$64.95
P/TBV (Annual)2.23x
Indicated Dividend (Annual)$0.96
Revenue Growth (3Y)5.85%
Cash Flow / Share (Quarterly)$5.73
Payout Ratio (TTM)27.01%
Price vs S&P 500 (YTD)2.12%
Gross Margin (TTM)69.71%
Net Profit Margin (TTM)8.56%
EPS (TTM)$3.55
10-Day Avg Trading Volume1.99M
EPS Excl Extra (TTM)$3.55
Revenue Growth (5Y)3.22%
EPS (Annual)$3.55
Dividend / Share (Annual)$0.96
ROI (Annual)3.49%
Gross Margin (Annual)69.71%
Net Profit Margin (5Y Avg)8.68%
Cash / Share (Quarterly)$3.03
P/E Basic Excl Extra (TTM)26.67x
Revenue Growth QoQ (YoY)10.90%
P/E Normalized (Annual)26.65x
ROA (Last FY)3.05%
Revenue Growth TTM (YoY)7.20%
EBITD / Share (TTM)$9.01
ROE (5Y Avg)5.22%
Operating Margin (TTM)13.34%
Cash Flow / Share (Annual)$5.73
P/B Ratio1.48x
P/B Ratio (Quarterly)1.40x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)3.12x
Net Interest Coverage (TTM)3.84x
ROA (TTM)3.08%
EPS Growth QoQ (YoY)-41.29%
EV / EBITDA (TTM)14.37x
EPS Incl Extra (Annual)$3.55
Current Ratio (Annual)1.98x
Quick Ratio (Quarterly)0.89x
3-Month Avg Trading Volume2.16M
52-Week Price Return-7.62%
EV / Free Cash Flow (Annual)22.97x
P/E Incl Extra (TTM)26.67x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$40.82
P/S Ratio (Annual)2.28x
Asset Turnover (Annual)0.36x
52-Week High$108.29
Operating Margin (5Y Avg)13.51%
EPS Excl Extra (Annual)$3.55
CapEx CAGR (5Y)7.11%
Tangible BV CAGR (5Y)9.21%
26-Week Price Return-4.23%
Quick Ratio (Annual)0.89x
13-Week Price Return3.01%
Total Debt / Equity (Annual)0.59x
Current Ratio (Quarterly)1.98x
Enterprise Value$25,718.58
Revenue / Share Growth (5Y)4.07%
Asset Turnover (TTM)0.36x
Book Value / Share Growth (5Y)2.07%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.10x
Pretax Margin (Annual)10.09%
Cash / Share (Annual)$3.03
3-Month Return Std Dev24.03%
Gross Margin (5Y Avg)71.04%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)27.30%
EBITDA Interim CAGR (5Y)-2.83%
ROE (Last FY)5.55%
Net Interest Coverage (Annual)3.84x
EPS Basic Excl Extra (Annual)$3.55
P/FCF (TTM)16.78x
Receivables Turnover (TTM)5.17x
EV / Free Cash Flow (TTM)22.97x
Total Debt / Equity (Quarterly)0.59x
EPS Incl Extra (TTM)$3.55
Receivables Turnover (Annual)5.17x
ROI (TTM)3.49%
Dividend Growth Rate (5Y)0.12%
P/S Ratio (TTM)2.28x
Pretax Margin (5Y Avg)10.23%
Revenue / Share (Annual)$41.43
Tangible BV / Share (Annual)$40.82
Forward P/E11.59x
Free OCF CAGR (5Y)7.09%
Price vs S&P 500 (52W)-37.45%
P/E Ratio (TTM)26.67x
EPS Growth TTM (YoY)-20.07%
Year-to-Date Return4.76%
5-Day Price Return1.26%
EPS Normalized (Annual)$3.55
ROA (5Y Avg)2.97%
Net Profit Margin (Annual)8.57%
Month-to-Date Return4.18%
Cash Flow / Share (TTM)$6.73
EBITD / Share (Annual)$9.01
EPS Growth (3Y)47.75%
Operating Margin (Annual)13.34%
LT Debt / Equity (Annual)0.55x
P/CF (TTM)11.07x
ROI (5Y Avg)3.46%
P/E Excl Extra (TTM)26.67x
LT Debt / Equity (Quarterly)0.55x
EPS Basic Excl Extra (TTM)$3.55
P/TBV (Quarterly)2.23x
Payout Ratio (Annual)26.99%
P/B Ratio (Annual)1.40x
Dividend / Share (TTM)$0.96
Inventory Turnover (TTM)1.10x
Pretax Margin (TTM)10.09%
Book Value / Share (Annual)$64.95
Price vs S&P 500 (13W)2.32%
Dividend Yield (TTM)1.01%
Beta0.59x
P/FCF (Annual)16.78x
Revenue / Share (TTM)$41.62
ROE (TTM)5.59%
52-Week Low$84.59
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.39
3.38
3.37
3.32
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ZBHZimmer Biomet Holdings, Inc. | 2.28x | 3.22% | 69.71% | 13.34% | $94.78 |
ISRGIntuitive Surgical Inc. | 16.35x | 18.22% | 66.00% | 29.27% | $458.08 |
EWEdwards Lifesciences Corp | 7.42x | 6.70% | 78.01% | 18.41% | $79.05 |
STESTERIS plc | 3.70x | 12.49% | 44.11% | 17.03% | $219.97 |
ALGNAlign Technology Inc | 3.29x | 10.30% | 68.27% | 13.53% | $185.02 |
SNNSmith & Nephew plc | 2.36x | 6.21% | 68.01% | 12.88% | $33.83 |
MSAMine Safety Incorporated | 3.40x | 6.82% | 46.46% | 19.83% | $165.17 |
ESTAEstablishment Labs Holdings Inc. | 8.96x | 20.04% | 69.32% | -18.48% | $64.51 |
ENOVEnovis Corporation | 0.65x | -6.05% | 58.16% | -50.09% | $25.20 |
CDRECadre Holdings, Inc. | 2.32x | 8.57% | 42.54% | 11.04% | $30.43 |
AVNSAvanos Medical, Inc. | 1.64x | -0.38% | 50.47% | -8.78% | $24.66 |
About
Zimmer Biomet is a leading designer and manufacturer of orthopedic reconstructive implants and surgical equipment, with dominant market positions in the United States, Europe, and Japan. The company derives approximately two-thirds of revenue from large joint reconstructions, with the remainder from trauma, sports medicine, and extremities products. In 2022, Zimmer spun out its dental and spine businesses to focus on orthopedic reconstruction.